Efficacy of sagenit in menopausal syndrome
- Авторлар: Smetnik VP1, Smetnik VP1
-
Мекемелер:
- Шығарылым: № 4 (2010)
- Беттер: 94-96
- Бөлім: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/246428
- ID: 246428
Дәйексөз келтіру
Толық мәтін
Аннотация
A double-blind placebo-controlled multicenter study of Sagenit was conducted in menopausal patients. Thirty-four women received the drug as a tablet (0.1 g) daily. Therapy was performed for 9 months. Placebo was also given to 36 patients during the same period. Sagenit turned out to be highly effective in abolishing neurovegetative and psychoemotional symptoms. Even when used long continuously for 9 months, the agent caused no adverse reactions, such as endometrial proliferation, and had no effect on the breast. Thus, the use of sagenit may be an alternative to hormonal replacement therapy.
Негізгі сөздер
Әдебиет тізімі
Қосымша файлдар
